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EYE MOVEMENT DESENSITIZATION AND REPROCESSING (EMDR)
IN THE TREATMENT OF POSTTRAUMATIC STRESS DISORDER:
DISMANTLING THE COGNITIVE COMPONENT
Karen Cusack, M.A.
Western Michigan University, 1997
Twenty-three individuals meeting diagnostic criteria for post traumatic stress
disorder were randomly assigned to either a standard EMDR treatment group or a
modified treatment group that omitted the cognitive reprocessing component of EMDR.
All subjects were assessed on a variety ofpretest posttest measures including the SCL-90R, the Impact of Events, the Structured Interview for PTSD, SUDS, and Validity of
Cognitions (VoC). Results ofrepeated measures ANOVAs indicate a significant decrease
across all pre to post measures, with these results being maintained at a 1 month follow
up. With the exception ofSUDs and SCL-90-R anxiety scores, there were no differences
between groups on any measure. The results support the hypothesis that the cognitive
reprocessing component ofEMDR is not essential to treatment outcome.
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INTRODUCTION
It has long been recognized that exposure to traumatic events can produce
psychological consequences. Even as far back as World War I the term "shell shock" was
used to describe the reaction of the soldiers to the stresses of war. It was not until 1980,
however, that these symptoms were grouped into the diagnostic category of Post
traumatic Stress Disorder (PTSD) (American Psychiatric Association, 1980).
Recent national epidemiological studies have estimated the prevalence of PTSD
in the general population from between one to two percent (Helzer, Robins, & McEvoy,
1987; Kulka, et al., 1988). A study that examined the prevalence of PTSD among crime
victims found that 27.8% of crime victims in a South Carolina sample met DSM criteria
for PTSD (Kilpatrick, Saunders, McMullan, Best, Vemonen, & Resnick, 1989). The
study also reported that 5 7.1% of completed rape victims had developed PTSD.
Although several predisposing factors have been noted in the development of
PTSD, such as alcoholism, dysthymia, and family history of a psychiatric disorder, the
single strongest predictor of developing PTSD is the duration and intensity of the stressor
(Choy & Bosset, 1992). Of those who do develop the disorder following a traumatic
event, as many as 80% of these individuals have at least one co-morbid diagnosis
(Freidman, 1996). Commonly, other anxiety disorders, depression, substance abuse or
personality disorders accompany PTSD. Clearly, this disorder represents a significant
problem and warrants increased research and attention from the psychological community.
1
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Solomon, Gerrity, & Muff (1992) reviewed the efficacy of treatments for PTSD,
including pharmacotherapy, behavioral treatments, cognitive-behavioral treatments,
psychodynamic therapy, and hypnotherapy. Overall, pharmacotherapy was successful at
alleviating symptoms of intrusion, but had no effect on avoidance symptoms. Side effects
and contraindications were also noted.

The behavioral treatments (systematic

desensitization and flooding) each produced improvement in the intrusive symptom
cluster; however, serious complications resulting from flooding were noted including
exacerbation of depression, relapse of alcoholism, and precipitation of panic disorder.
One form of cognitive-behavior therapy, Stress Inoculation Training (SIT), was reported
superior to flooding; however, at three months flooding was superior in reducing the
symptoms of PTSD. Psychodynamic therapy and hypnotherapy showed significant
reductions in avoidance and intrusion symptoms, respectively. The potential negative
effects and limited symptom clusters treated with these types of therapies suggest the need
for more effective and safe treatments for PTSD.
Eye Movement Desensitization and Reprocessing (EMD/R) has emerged as a new
treatment that boasts rapid and dramatic reductions in symptoms of Posttraumatic Stress
Disorder (PTSD). The treatment technique was developed by Francine Shapiro in 1989.
The technique consists of exposure to the relevant traumatic images and cognitions,
saccadic eye movements, focusing on the physiological aspects of the anxiety related to
the trauma, the development of a positive cognition, and therapist controlled thought
stopping.
The first controlled study (Shapiro, 1989) reported dramatic results that were
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obtained in one session in treating individuals with a wide variety of different types of
traumatic memories. The results revealed a lasting reduction in anxiety, changes in
cognitions associated with the trauma, and cessation of intrusion symptoms. Since that
time numerous case studies have applied the technique to an adult PTSD population
(Kleinknecht & Morgan, 1992; Lipke & Botkin, 1992; Marquis, 1991; Puk, 1991; Spates
& Burnette, 1995; Thomas & Gafner, 1994; Vaughan, Wiese, Gold & Tarrier, 1994;
Wolpe & Abrams, 1991), child PTSD population (Coco & Sharpe, 1993; Pellicer, 1993),
Panic Disorder (Goldstein & Feske, 1994), Body Dysmorphic Disorder (Hassard, 1993),
phobias (Kleinknecht, 1993), and sexual dysfunction (Wernik, 1993).
Several controlled studies have also been reported ( Bauman & Melnyk, 1994;
Boudewyns, Stwetka, Hyer, Albrecht & Sperr, 1993; Foley & Spates, 1995; Forbes,
Creamer & Rycroft, 1994; Hekmat, Groth & Rogers, 1994; Jensen, 1994; Montgomery
& Ayllon, 1994a; 1994b; Renfrey & Spates, 1994; Sanderson & Carpenter, 1992;
Vaughan, Armstrong, et al., 1994; Wilson, Becker & Tinker, 1995).
Boudewyns, Stwettka, Hyer, Albrecht & Sperr (1993) compared EMD/R to an
exposure control procedure in treating traumatic memories. Twenty subjects were
randomly assigned to either a standard EMDR protocol (n=9), an exposure control
protocol (n=6), or to milieu treatment on an inpatient unit of a V.A. medical center (n=5).
The subjects were all male Vietnam combat veterans. The study utilized a pre-test post
test comparison group design.
The EMDR group received two 90:minute sessions of standard EMDR. The EC
group was asked to recall the memory in the same manner and for the same amount of
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time as the EMDR subjects, but without the eye movements. Treatment was carried out
over a 14 day period. Subjects were assessed one week following treatment on the
CAPS, IES Intrusion and Avoidance scales, and the Mississippi scale. Other dependent
measures included: (a) SUDS taken during treatment, (b) SUDS taken during a taped
playback of intake report of trauma, (c) heart rate reactivity recorded during taped
playback of initial report of trauma, (d) Electromyogram recorded during taped playback,
(e) hand temperature recorded during taped playback, and (f) therapist rating of treatment
response.
The results revealed a significant decrease in SUDS scores taken during treatment
for both treatment groups. The EMDR group showed significantly greater reductions in
the SUDS than the EC condition. There were a significantly greater number of EMD/R
clients who were rated as treatment responders by the therapists.

There was no

significant change in the pre and post SUDS taken during the taped playback. There were
no significant findings on any of the psychophysiological measures or the standardized
psychological measures.
This study had a

small number of subjects in each group which makes

interpretation of the findings limited. Also, the number of treatment sessions was limited
to only two. The decision to limit the number of sessions was based on the fact that
Sharpiro reported dramatic improvement with only one session. Significant treatment
effects may have been found if the sessions were not limited in this way. The use of
standardized measures and psychophysiological measures are strong features of the study.
This is an improvement upon earlier studies, including Shapiro's initial study (1989a) that
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did not make use of standardized or objective measures.
Jensen (1994) evaluated the effectiveness ofEMD/R with a group of Vietnam
combat veterans suffering from PTSD. Using a pretest posttest control group design,
twenty-five subjects were randomly assigned to either the standard EMD/R treatment
condition or control.

Jensen included two standardized measures of PTSD: The

Structured Interview for PTSD (SI-PTSD) (assessed at pre- and post-test), and the
Mississippi Scale for Combat-related PTSD (M-PTSD) (assessed only at post-test); also,
the Goal Attainment Scaling (GAS) was added as a measure that assessed at post-test
whether a previously specified PTSD goal was attained.
Using an analysis of covariance, the results of the study showed no differences
between groups on any measure except for the SUDS. On this measure, the EMDR group
did have significantly lower SUDS ratings, but it was not a clinically significant decrease.
The author concluded that the present study failed to support the effectiveness ofEMDR
with combat veterans.
This study addresses two important issues raised in the literature. One, the use
of a standardized PTSD measure for assessing PTSD symptomology; and two, the use
of Vietnam combat veterans as subjects. Only two studies to date have attempted to
evaluate EMDR with a group of combat veterans, one of the largest groups of chronic
PTSD sufferers (Boudewyns, Stwetka, Hyer, Albrecht, & Sperr, 1993; Silver, Brooks &
Obenchain, 1995).
There are three principal weaknesses of Jensen's study. First, the no-treatment
control group was informed that they would not be receiving the treatment and was given
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a list of local alternative sites for treatment. This shows that there was no control over
what did occur for this group during the time period of the study. It is possible that while
no differences were found between groups, that the control group was receiving some
type of treatment that may have been affecting their outcome measures also. In this case,
a finding of no relative effect of treatment for the EMDR subjects may be misleading.
Second, all of the subjects in the study were Vietnam combat veterans, 36% of
which were receiving compensation from the U.S. for their service-connected PTSD
disorder. Previous researchers have pointed out that a negative finding of a treatment for
PTSD with combat veterans may be explained by a loss of financial compensation upon
reporting PTSD symptom reduction (Boudewyns, et al, 1993; Lipke & Botkin, 1992).
Third, with respect to the negative findings in this study it is important to note that
the subjects only received two EMDR treatment sessions. It seems reasonable to assume
that combat veterans who have been suffering from PTSD for many years probably have
many traumatic memories that could be targeted for treatment. Perhaps the lack of
success with the EMDR treatment is a result of the subjects not being exposed to all of
the traumatic memories giving rise to their distress.
An interesting finding with respect to the SI-PTSD is that for both groups, SI
PTSD scores actually increased from pre to post. The difference between the groups
however was not significant. The analysis of the results was performed on incomplete
data. The first 4 subjects did not report SUDS and VoC ratings prior to treatment, and
2 other subjects did not give VoC ratings following treatment.
In a study by Vaughan, Armstrong, Gold, O'Connor, Jenneke, and Tarrier (1994)
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EMDR was compared to two other treatments - image habituation training (IHT) and
applied muscle relaxation (AMR). The study employed a pretest posttest comparison
group design. Thirty-six subjects who met partial DSM-III-R criteria for PTSD were
included in the study. All subjects met criteria A, B, and D; however, 22% of the subjects
failed to qualify for the diagnosis of PTSD because they had less than the required three
Category C (Avoidance/numbing) symptoms. The types of traumatic events experienced
by the subjects included: victim of violent crime, rape, child abuse, and motor accident.
Co-morbid diagnoses of Panic Disorder were made for 11 patients (31%), Generalized
Anxiety Disorder in 20 (55%), and Major Depression in 6 (17%).
Subjects were randomly assigned to one of four conditions: EMD, IHT, AMR,
or a wait list control group. All treatment groups received four sessions. For the EMD
group, all therapists were trained by Shapiro and the protocol was reported as that
described by Shapiro. For the IHT group, subjects were required to listen to continuous
loop audiotaped descriptions of their trauma and to record cognitions and anxiety levels
on a homework sheet for 60 minutes per day. The AMR group subjects were taught to
recognize early signals of anxiety so that they could then apply the relaxation technique
described by Ost (1987). These subjects were instructed to practice the relaxation
technique for two 20-minute periods per day. The authors presented no information
regarding whether or not the relaxation was actually practiced as instructed.
Assessment measures included two structured interviews, the Structured Interview
for PTSD (SI-PTSD) and the Anxiety Disorders Interview Schedule Revised (ADIS-R).
The SI-PTSD was used to diagnose PTSD as well as assess PTSD symptomology change.
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The ADIS-R was used to obtain measures of Generalized Anxiety Disorder and Panic
Disorder. The Hamilton Rating Scale for Depression (HRSD) was used as a measure of
depression. Selfreport measures included the State-Trait Anxiety Inventory (STAI), The
Beck Depression Inventory (BDI), and the Impact of Events Scale (IES).
Results comparing post-wait list to post-treatment scores on the SI-PTSD and
HRSD revealed a significant effect of treatment. All treatments were superior to no
treatment for Category C and D (Avoidance and Hyperarousal symptoms) and HRSD yet
failed to reach significance for Category B (reexperiencing) symptoms. In addition, at
entry to the study, 78% of subjects were diagnosed with PTSD. At post-test this figure
was 4 7%, and 30% at a 3 month follow-up. The effects of individual treatment on
measures of symptomatology revealed significant improvement from pre to post test, with
no significant differences between treatment groups. Only EMD produced significant
improvement in Flashbacks and Nightmares at posttreatment and follow-up. Significant
improvement in the Avoidance symptoms occurred only for the EMD group.
Hyperarousal symptoms improved significantly with both EMD and IHT. Panic Disorder
was eliminated in the EMD group, although one subject relapsed at follow-up. For all
treatment groups, there was a reduction in GAD diagnoses. There was significant
improvement on HRSD scores at posttreatment and follow-up for both EMD and AMR.
The treatment comparison used in this study provided a substantial design feature
addition to the EMDR literature. Due to the fact that the results failed to demonstrate
consistent superiority of any one treatment over any other, no definite conclusions about
the relative efficacies of the three treatments can be made. Although the results of this
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study indicate that the treatments were equally effective, there are several reasons why
replication is needed before EMD can be evaluated against the other treatments. First,
the initial scores on the SI-PTSD for these subjects are on the low end compared to most
PTSD patients. The authors of the SI-PTSD, Davidson, Smith, & Kudler (1989) state
that scores on each of the questions need to be at least a 2 in order to be considered
significant distress. Based on this, the scores obtained on each of the Categories B, C,
and D, as well as total symptom scores, did not comprise significant distress. This is
something to note, simply in that with more distressed patients there may be differential
treatment effects.
Replication is also needed because this study used a limited number of treatment
sessions, with both the IHT and AMR groups receiving homework outside of the
sessions. Therefore it is difficult to say whether subjects in the three groups were
receiving equivalent doses of therapy.
Another study that addressed a clinical population was reported by Forbes,
Creamer and Rycroft (1994). This study selected 8 subjects who all met DSM-111-R
criteria for PTSD. All subjects received 4 - 90 minute sessions ofEMDR. Due to high
drop out among control group members, the study was run without a control group.
Subjects were assessed using two structured interviews, three self-report measures, and
a physiological measure ofmuscle tension at pre-treatment, one week posttreatment, and
a 3 month follow-up. The interviews consisted of the SI-PTSD (to assess PTSD
symptomology) and the SCID (to determine presence of co-morbid diagnoses). The
SCID was included to see ifEMDR treatment effects could generalize to the existing co-
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morbid symptomology. The self-report measures included: the Symptom Checklist-90Revised (SCL-90), Global Severity Index (GSI), Impact of Events Scale (IES), and the
Beck Depression Inventory (BDI). A suggestibility scale was also included (Stanford
Hypnotic Clinical Scale) to investigate the effects of suggestibility on treatment outcome.
The therapists were trained by Shapiro and standard EMDR protocol was used.
Based on the SCIO, three subjects met criteria for a diagnosis of Major
Depression. At follow-up, only one subject still met the criteria. Data on the SI-PTSD
revealed significant effects for each of the three symptom categories (re-experiencing,
avoidance and hyperarousal), as well as for total PTSD severity. There was significant
improvement from pre- to posttreatment, with no further change from posttreatment to
follow-up.

Clinically significant improvement was also investigated based on the

guidelines of Jacobson and Truax (1991) that subjects be more than two standard
deviations below the mean of the pretreatment sample at posttreatment (or follow-up).
Based on the SI-PTSD scores, 75% (n=6) showed significant improvement at
posttreatment; this figure dropped to 62% (n=5) at follow-up. The authors report that
four subjects (50%) continued to meet the criteria for a full diagnosis of PTSD at both
posttreatment and follow-up. For the self-report measures (SCL-90-R, IES & BDI),
significant improvement was obtained on all measures. The significant differences were
found from pre- to posttreatment, with no changes from posttreatment to follow-up.
With regards to the EMG measure, the authors reported that missing data did not allow
t-tests to be performed, however, effect size analyses revealed large reductions in EMG
from the first to last session in the baseline condition (.99), while moderate reductions
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were apparent while subjects were imagining the trauma (.61). Pearson correlation
coefficients revealed a significant relationship between EMG levels and overall symptom
improvement on the SI-PTSD (r=.96, p<.05). SUDS levels were reported only as means:
beginning of first session (mean= 8.5, SD=2.0) and end of first session (mean=3.0,
SD=3.58). A significant relationship was found for suggestibility and treatment outcome,
(r=.86, p<.05). This relationship was accounted for solely by reductions in the SI-PTSD
"avoidance" symptom cluster.
The results of this study need to be interpreted with caution due to both the small
sample size and the lack of any control group. The use of the structured interview to
assess PTSD symptomology provides for a more standardized assessment of symptom
change, and is an asset to the study. Also the evaluation of the clinically significant
improvement provides additional important information. There is a need for more studies
on EMDR to incorporate these types of analyses.
In the most well controlled study to date, Wilson, Becker and Tinker (1995)
treated 80 participants suffering from traumatic memories with either standard EMDR or
a delayed treatment condition. Participants received no other type of therapy while
involved in the study. All therapists in the study were trained by Shapiro. Several
standardized psychological measures were used including the Impact of Events, SCL-90R, and the State-Trait Anxiety Inventory. Results revealed a statistically significant
decrease in symptoms reported for the EMDR group from pretest to a 1 week posttest,
with results maintained 90 days later. For the delayed treatment condition, there was no
significant change from pretest 1 to pretest 2, however there was a significant change
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following treatment that was maintained at the 90 day follow-up. Clinical significance
was also examined using normative data for the SCL-90-R, IES, and the STAI. Prior to
beginning treatment, subjects scores were above the normal range on each variable.
Following treatment the means all fell within the normal range. Effect size analyses
revealed an effect size of1.82 on the trauma-specific measures (SUDS, IES Intrusion,
IES Avoidance) and an effect size of.65 on the general measures (SCL-90-R and STAI).
This study provides very strong support for EMDR's effectiveness in treating PTSD
symptoms.

Overall, the results of these studies clearly support the effectiveness of

EMDR. While it appears that the technique is effective in reducing symptoms ofPTSD,
it is unclear why.
Several investigators have attempted to evaluate the role ofeye movements in the
EMD/R procedure. Sanderson and Carpenter (1992) compared what was reportedly eye
movement desensitization to image confrontation in a crossover design that utilized 58
spider phobics. The two procedures were reportedly identical with the exception ofthe
eye movements in the EMD group. The two procedures were equally effective in
reducing anxiety levels. Although this study appears to support the conclusion that eye
movements are not a necessary component, there are methodological problems that limit
the conclusions. The EMD procedure was not standard EMD. The procedure actually
resembled image confrontation plus eye movements rather than EMD. Also, no
standardized or objective measures were used.
Renfrey and Spates (1994) evaluated the role of eye movements by comparing
three conditions: (1) standard EMD, (2) a variant ofEMD in which eye movements were
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engendered through a light tracking device, and (3) a variant of EMD in which fixed
visual attention replaced eye movements. Twenty-three PTSD patients were exposed to
one of the three conditions. Results revealed that all three interventions produced
significant improvements across all dependent measures.

The measures included

Subjective Units of Disturbance (SUDS), Impact of Events Scale (IES), Symptom
Checklist-90-Revised (SCL-90-R), and heart rate reactivity. The authors concluded that
the eye movements are not essential to treatment outcome. However, the small number
of subjects in this study does limit the generality of the findings.
Montgomery and Ayllon (1994) used a multiple baseline across subjects to
evaluate whether the saccadic eye movements are central to treatment. All six subjects
were exposed to first, a non-saccade phase, followed by a second phase that included the
saccadic eye movements.

Dependent measures included SUDs and physiological

measures (heart rate and blood pressure). Results revealed no significant decreases in
SUDs levels with the EMD minus eye movements procedure. However, significant
decreases in SUDs were reported following the second phase for five of the six subjects.
The authors concluded that the eye movements are necessary to produce treatment gains.
There are several methodological problems that limit any conclusions regarding
the role of the eye movements in this study. First, the EMD minus eye movements
condition was reported to be identical to the standard EMD condition. There were
however, substantial differences in the two procedures. The EMD minus eye movements
condition did not have subjects blank out the image and take a deep breath, nor did it
involve the therapist asking for the changes that have occurred in cognitions or
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physiology. The more obvious problem with this study in using a multiple baseline design
is that all subjects received the two treatments in the same order, so that treatment effects
after phase 2 (standard EMD) may have just been the result of an increased number of
treatment sessions. Finally, subjects received an average of 3 sessions of the EMD minus
eye movements and 6 sessions of the standard EMD. Therefore, the conclusion that the
difference between groups and hence, the essential component, is eye movements is of
questionable validity.
Foley & Spates (1995) examined the role of the eye movements with 40 college
students who suffered from public-speaking anxiety.

All of these subjects had

experienced a specific traumatic speech related event. Subjects were randomly assigned
to either a standard EMD/R protocol incorporating eye movements; a moving audio
stimulus in place of the saccadic eye movements; a protocol with eyes resting on the
hands in place of the saccadic eye movement, or a no-treatment control condition. The
subjects' anxiety level was assessed using self-report measures of anxiety, heart rate
reactivity, and a behavioral assessment of speech anxiety. Results revealed significant
improvement on all measures except heart rate reactivity, which showed no change.
Further, there were no significant differences between groups, suggesting that eye
movements are not an essential component insofar as outcome measures were concerned.
Bauman & Melnyk (1994) evaluated the efficacy of the EMDR procedure with
test anxious students. Fifteen pairs of students_, who were matched on initial test anxiety,
were randomly assigned to EMDR or a_control condition (finger tapping). The finger
tapping condition was identical to the standard EMDR condition except that finger
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tapping replaced eye movements. The purpose of the study was to determine whether
EMDR effectively treats test anxiety and, if so, whether eye movements are the critical
factor.

Results revealed that the two conditions produced equally significant

improvements on the SUDs and the Test Anxiety Inventory.
Although the data are not conclusive, it appears that eye movements are not an
essential outcome-determining feature of the treatment. Other possible components that
may be responsible for producing the positive effects include the exposure to the negative
images or cognitions associated with the trauma, and the development and rehearsal of
a positive (adaptive) cognition. To date, no study has attempted to systematically
evaluate the effects of either of these components. Further, there have been few well
controlled investigations that clearly establish the efficacy of these treatments when
administered alone for PTSD.
While research on cognitive therapy has demonstrated it to be a highly effective
treatment for depression (Dobson, 1989; Robinson, Berman, & Neimeyer, 1990) as well
as for J>anic disorder (Margraf, Barlow, Clark, & Telch, 1993), these effects have not
been as clearly demonstrated in the PTSD literature.
In a variation of cognitive therapy, two studies found Stress Inoculation Training
(SIT) superior to an exposure type therapy (exposure or flooding) with a PTSD
population at post test (Veronen & Kilpatrick, 1983; Foa et at., 1991). Two other studies
found cognitive therapy (cognitive-behavioral therapy or SIT) as effective as systematic
desensitization or supportive psychotherapy (Frank et al., 1988; Resick et at., 1988).
However each of these studies is limited by high drop out rates. Also, in the Veronen &
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Kilpatrick study, non-random assignment to treatment groups prevents conclusions
regarding the results. Further, the results of the Foa study indicated a reverse outcome
at follow-up, with exposure superior to SIT. Taken together these findings suggest
equivocal outcomes at best for the cognitive treatment of PTSD, and commends
additional research.
Similarly, while "exposure" has been accorded the status of a principle in
explaining the effects ofEMD/R, investigations of exposure as a stand alone treatment
suggest the need for further work. Using a variation of exposure therapy, Vaughan and
Tarrier (1992) treated ten patients with image habituation training. Results revealed that
six improved considerably, two showed moderate improvements, and two showed
minimal improvement across a range of self report measures. Other investigators have
found differential treatment outcome for individual symptom clusters of PTSD. Keane,
Fairbank, Caddell & Zimering (1989) found implosive (flooding) therapy produced
significant improvements in the re-experiencing dimension of PTSD, anxiety, and
depression; however, there was no change in the numbing and avoidance symptoms.
Similarly, Cooper & Clum (1989) found that imaginal flooding produced significant
improvement in subjective anxiety and sleep disturbance; however, there was no treatment
effect on depression or trait anxiety. Therefore, as with cognitive therapy for PTSD,
exposure treatment also requires substantially greater investigation before it can provide
a basis for understanding the mechanism of action ofEMD/R.
Research from cognitive dismantling studies in related areas reveals mixed findings
with respect to the role of the cognitive component in treatment. Marshall (1985) treated
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height phobics with either an exposure alone or exposure plus cognitive component. He
found that the cognitive component appeared to add nothing significant at posttest;
however, by follow-up continued improvements were found for the combined exposure
and cognitive treatment.
In a cognitive dismantling study of cognitive-behavioral treatment of depression,
a behavioral activation condition (BA) was compared to a modifying automatic thoughts
(AT), and combined treatment package of cognitive-behavioral treatment (CT) (Jacobson,
et al., 1996). Results revealed significant improvement with no differences between
groups, indicating that the behavioral and cognitive components were as effective as the
combined treatment package. Interestingly, they also found that the behavioral condition
was actually more likely to produce changes in attributional style than the cognitive
conditions.
Barlow and colleagues (Margraf, Barlow, Clark & Telch, 1992) conducted a
series of studies on panic control treatment in which the cognitive component was
dismantled. Based on their research, the contribution of the cognitive component
appeared to lie in preventing drop-out and relapse, and not in producing direct outcome
changes.
Problem Statement
In order to understand the mechanisms ofEMDR, the present study attempted to
evaluate the role of the cognitive reprocessing component. In this study, the EMDR
procedure was compared to the standard procedure minus the cognitive component.
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Therefore, when referring to Shapiro's standard procedure, the term EMD/R has been
adopted. When referring to the procedure that excludes the cognitive reprocessing
component, the term EMD is used. The effects of the two interventions were evaluated
across SUDs, as well as standardized objective measures of PTSD symptomology (Impact
of Events Scale and the Structured Interview for PTSD).
It was hypothesized that (a) the presenting complaints associated with the
traumatic memories would be reduced or eliminated as a result of treatment; (b) self
report of anxiety would decrease; (c) positive self-cognition would increase; and (d) no
differences would be found between treatment groups at post-test. Due to the nature of
the mixed results in the literature regarding the effects of a cognitive component on
treatment outcome at follow-up, in the present study we hypothesized that the null
hypothesis of no change from post to follow-up would be retained.

METHOD
Participants
A total of 106 individuals were referred to the study. Of these 106 potential
subjects, 42 decided not to participate, 32 were screened out, and 8 individuals dropped
out of the study once treatment began. The remaining 23 subjects completed the study.
There were 20 female and 3 male participants, ranging in age from 18 to 51 years old
(M=35). All subjects were experiencing traumatic memories and met either full (65%)
or partial criteria (35%) for PTSD.

The types of traumatic events included

rape/molestation (35%), robbery (15%), emotional/psychological abuse (15%),
automobile accident (10%), physical assault (10%), death of child (10%), and witnessing
a traumatic event (5%).
Subjects were recruited from the community through newspaper advertisements,
public postings, referrals from members of local professional and human service
organizations, as well as appropriate referrals from private practitioners in the community,
The University Psychology Clinic, hospital emergency rooms and trauma centers.
Potential subjects were evaluated for co-morbid psychiatric diagnoses to exclude
individuals with symptoms consistent with a DSM-IV borderline personality diagnosis,
obsessive-compulsive personality diagnosis, psychotic thinking, or substance abuse (using
the DSM-IV criteria for personality disorgers, SCL-90-R, and DAST, respectively) (See
below for a description of scales).
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All subjects were assessed for symptoms of post-traumatic stress disorder and had
to meet a partial diagnosis of PTSD. All subjects had to have experienced a traumatic
event as defined by part "A" of the DSM-IV diagnostic criteria for PTSD. In addition,
subjects had to meet diagnostic criteria for at least 2 of the 3 main PTSD symptom
clusters.
Experimental Design
A pretest posttest comparison group design was used. All participants were
randomly assigned to either the standard EMDR group or the modified treatment group
that omitted the cognitive reprocessing component (EMD). This component requires that
the subject develop and focus on a positive (adaptive) cognition.
Setting
All assessment and treatment sessions were conducted in individual therapy rooms
at the University Psychology Clinic. Each room was equipped with direct observation
capabilities as well as videotaping facilities. All assessment sessions were conducted by
trained research assistants who were upper level undergraduate psychology students. All
therapists were doctoral students who had been trained for 8 weeks by a senior clinical
psychologist who had himself received training in EMDR by Shapiro.
Dependent Variables
The dependent variables in this study include: subjective distress ratings (SUDS),
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validity ratings of positive belief statements (VoC), anxiety scores (SCL-90-R & a
behavioral rating ofanxiety), depression scores (SCL-90-R), and PTSD symptomology
scores (SI-PTSD & IES). The SUDS and VoC ratings were taken throughout the
treatment procedure and were used to gauge the need for additional sessions. The VoC
ratings were taken only for the EMDR group.

This analysis is included in the

supplementary analyses section. The other dependent variables were assessed at either
post-treatment (using the SCL-90-R and IES), or at the one month follow-up (using the

SI-PTSD).
Each ofthe dependent variables was assessed using subjects' selfreport with the
exception of the behavioral rating of anxiety taken during both the initial session and
follow-up sessions. While selfreport measures have been criticized due to their lack of
objectivity, their appropriateness can be argued in this instance on grounds ofvalidity.
The diagnostic criteria for PTSD requires an individual to report on private symptoms.
Therefore, it is the subject's self report that most directly confers the disorder or
improvement.
Measures
A number ofclinical assessment instruments were used in conducting this study,
including: the Structured Interview for Post-traumatic Stress Disorder (SI-PTSD)
(Davidson, Smith & Kudler, 1989), The Revised Symptom Checklist (SCL-90-R)
(Derogotis, 1977), Impact ofEvents Scale (IES) (Horowitz, Wilner & Alvarez, 1979),
the modified Behavioral Assessment ofSpeech Anxiety (BASA-modified) and the Drug
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Abuse Screening Test (DAST) (Gavin, Ross & Skinner, 1989). The Subjective Units of
Discomfort (SUDs) and Validity ofCognition (VoC) were also used in the present study
as process measures taken during treatment. The SUDs was also taken at the 1 week
posttest and the 1 month follow-up periods.
The SI-PTSD is a 13-item self-report questionnaire measuring the intrusion,
avoidance, and increased arousal symptoms ofPTSD. Each item is rated on a 4-point
scale, with the total score ranging form O to 52. Davidson, Smith & Kudler reported
internal consistency and test-retest reliability estimates of .94 and . 71, respectively.
Concurrent validity was established by correlation of.79 with Spitzer and Williams()
(1985) Structured Clinical Interview for Diagnosis ofDSM-III. In this study the SI
PTSD was used to establish the primary diagnosis requiring treatment and to determine
symptom remission following treatment at a l month follow-up. (See Appendix A)
The SCL-90-R is a 90-item self-report questionnaire that measures nine primary
current symptom dimensions and three global indices ofdistress. Each ofthe 90 items are
rated on a 5-point scale of distress (0-4). Derogatis (1983) reported the internal
consistency to range from .77 to .90 for the various symptom dimensions. Test-restest
reliability was found to be between .80 and .90 for the nine symptom dimensions. (See
Appendix B)
The IES is a 15-item self-report questionnaire measuring two dimensions of
PTSD: event-related intrusion and avoidance. The frequency of these symptoms is
indicated on a 4-point scale. Horowitz. et al. reported split-halfreliability for the total
scale to be .86, internal consistency ofthe subscales (CronbachOs alpha) to be .78 for
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intrusion and .80 for avoidance, and test-retest reliability (one week) to be .87. (See
Appendix C)
The DAST is a 28-item self-report questionnaire that measures vanous
consequences of drug use that are combined in a total DAST score to yield a quantitative
index of problems related to drug misuse. Skinner reported the internal consistency
reliability estimate to be .92.

Factor analysis suggested a unidimensional scale.

Concurrent validity was examined by correlating the DAST with background variables,
frequency of drug use during the past 12 months, and indices of psychopathology. (See
Appendix D)
A personality assessment based on DSM-IV diagnostic criteria for Borderline and
Obsessive-compulsive personality disorders was created for the purposes of the present
study. Subjects were read a list of statements taken directly from the DSM-IV and were
asked to indicate if this was not characteristic (score=0), a little bit / sometimes
characteristic (score=1), or defi nitely characteristic of them (score=2). This criteria was
used as a basis for screening. (See Appendix E)
A modified version of the Behavioral Assessment of Speech Anxiety (BASA) was
used during the initial and follow-up assessment sessions while the SI-PTSD was
administered. Trained observers were present for each of these sessions to rate the
behavioral signs of anxiety (shortened breath, wringing hands, rapid speech). (See
Appendix F) The observers were trained using video clips that depicted behavioral
expressions of anxiety in the actors. .Training continued until an acceptable level of
agreement was consistently reached. Half-way through the study, observers went through
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the training procedure again to insure consistency in scoring. In addition, bi-weekly
meetings were held in which any difficulties in scoring were addressed.
Treatment Integrity
In order to ensure that each of the two interventions was properly administered,
trained observers viewed a sample of the treatment sessions (15%). Two observers were
provided with a checklist that outlined the steps in each of the two treatments. (See
Appendix G). Observers were blind to the treatment they were observing. The observers
viewed the videotapes separately and checked off the presence of each of the steps
outlined and concluded with a judgment as to which treatment procedure was used. An
inter-rater reliability check was performed on the final judgement that examined the
number of agreements divided by the number of agreements plus disagreements. This
procedure yielded an inter-rater reliability of 100%.
Procedure
Subjects attended two separate screening sessions at the Psychology Clinic. In
the first sessions, subjects signed an informed consent that described what participation
entailed (Appendix H). Subjects then completed the SCL-90-R to determine if they
should be excluded on the basis of psychotic thinking. I-scores above a 65 on this scale
resulted in exclusion from the study. The DASI was administered to screen for current
drug or alcohol abuse. Scores on the DASI above 9 resulted in exclusion. For each of
the borderline and obsessive-compulsive scales on the personality assessment, subjects
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were screened from the study if they scored a mean of 1 on either scale. All remaining
subjects who were not excluded based on the initial screening session were scheduled for
the structured interview.
The interviews were conducted by two trained interviewers who were clinical
doctoral students. Subjects were asked about any traumatic experiences they had
encountered. If subjects reported multiple traumas they were asked to describe the three
worst traumas, and were interviewed on each trauma separately. Subjects needed only
to meet the diagnostic criteria for one trauma; however, if they did meet criteria for more
than one trauma data was collected on the additional traumas throughout the study.
The diagnostic criteria for the study included that subjects had to have experienced
a traumatic event as defined by part "A" of the DSM-IV diagnostic criteria for PTSD.
In addition, subjects had to meet the criteria for at least 2 of the 3 main symptom clusters
(B,C,and D). Criteria B requires at least one symptom of re-experiencing the event
(flashbacks, nightmares), Criteria C requires at least three symptoms of avoidance of the
trauma and numbing of general responsiveness, and Criteria D includes at least two
symptoms of increased arousal (ie. sleeping disturbances, hypervigilance, exaggerated
startle response). These symptoms had to have occurred for a period of at least one
month.
During the interview session subjects also completed the Impact of Events Scale.
Again, if multiple traumas were reported, subjects completed a separate IES on up to 3
traumas. The IES was used as a pretest·posttest measure of PTSD symptomology.
Subjects who qualified were then randomly assigned to a treatment group and

therapist. All subjects attended between 1-3 90 minute treatment sessions. The EMOR
group received Shapiro's standard EMOR treatment (See Appendix I). Subjects in the
EMO group received the identical treatment, but without the cognitive reprocessing
component (See Appendix J). In this group the subjects followed the standard procedure
but were not asked to develop a positive cognition and assign a VoC to it, nor did
treatment include the installation phase where the positive cognition is held in mind along
with the traumatic image. In order to ensure that the treatment conditions were otherwise
parallel, subjects in the EMO group received an additional 4 sets of the saccadic eye
movements, mirroring the EMOR condition's installation phase. Following treatment
subjects were scheduled for the I week posttest. At the completion of treatment, any
subjects that reported significant anxiety remaining were provided with a referral for
further treatment.
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RESULTS
Preliminary Analysis
Drop-outs vs. Completers
Three males and five females who were selected to participate did not complete
the study. These individuals each had from 1 to 2 treatment sessions before dropping out
of the study. One subject moved out of town and was no longer able to come to the clinic
for treatment. Five subjects stated that they were uncomfortable with addressing the
traumatic memories in treatment at this time. The other two subjects dropped out and
were unreachable from that point on.
A one way analysis of variance revealed a significant difference between the
participants who dropped out of the study and those that completed on the SCL-90-R
Depression (p<.05) & GSI (p<.05), IES Intrusion (p<.05), SI-PTSD Category B score
(p<.05), Category D score (p<.05) and Total score (p<.05) (See Table 1).
Treatment Conditions
There were 2 males and 9 females in the EMD condition. There was 1 male and
11 females in the EMDR condition. A one way ANOVA revealed no pretreatment
differences between the EMD and the EMDR group on any measure. The mean number
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of treatment sessions for the EMD group was 2.75. For the EMDR group the mean
number of sessions was 2.92. The types of traumatic events that subjects were exposed
to was evenly distributed between groups (Table 2).
Table 1
Comparison of Mean Scores of Treatment Completers Vs. Dropouts
Dropouts
Completers
=
N 23
N=8
2.4 (1.1)
1.9 (.7)
SCL-90-R Anxiety
SCL-90-R Depression

1.8 (.8)

2.5 (.8)*

SCL-90-R GSI

1.5 (.6)

2.0 (.6)*

SCL-90-R PSDI

2.3 (.4)

2.5 (.6)*

IES Intrusion

2.1 (.6)

2.7 (.5)

IES Avoidance

2.2 (.5)

2.4 (.3)

SI-PTSD B

11.3 (3.6)

14.4 (3.8)*

SI-PTSD C

11.2 (6.0)

15.1 (4.7)

SI-PTSD D

9.7 (3.4)

13 (3.9)*

SI-PTSD Total

32.3 (10.8)

42.1 (9.5)*

BASA

9.8 (6.2)

12.6 (5.2)

*Significant at .05 level
Primary Analyses
A two factor repeated measures analysis of variance was conducted for each of
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the primary dependent measures (SCL-90-R anxiety, depression, GSI, PSDI, IES
intrusion, IES avoidance, SI-PTSD, BASA, and SUDs scores). For each of the measures,
the data are presented graphically for visual inspection, the appropriate statistical analysis
is described, and the means and standard deviations are displayed· in table form. (See
Table 3).
Table 2
Types of Traumatic Events by Group

EMD

EMDR

Sexual Assault (N=5)

Sexual Assault (N=3)

Automobile Accident (N=2)

Automobile Accident (N=1)

Physical Assault (N=2)

Physical Assault (N=2)

Death of Child (N=1)

Death of Child (N=1)

Accusations of Abuse/Loss

Robbery (N=3)

of Son (N=l)

Accusations of Abuse/Loss of Son (N=1)
Witnessing a Traumatic Event (N=l)

Figure 1 displays the change from pretest to post-test in group means for the SCL90-R anxiety scores. A consistent decrease in mean scores is evident for both groups.
The repeated measures ANOVA conducted on the SCL-90-R anxiety scores (2 groups
x 2 assessment periods) revealed a signific;ant effect for treatment group, F(l,21) = 4.39,
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p<.05, and a significant effect for assessment phase, F(l,21) = 14.14, p<.001. There was
no significant treatment by phase interaction. An independent t-test was conducted on
the mean post-test scores of the SCL-90-R anxiety subscale and revealed no significant
difference between the mean of the EMD group and the mean of the EMDR group.
Table 3
Means, Standard Deviations, and Effect Sizes on Outcome Measures
EMD

Effect Size

EMDR

Effect Size

SCL-90-R
Anxiety (Pre)

2.13 (.74)

Anxiety (Post)

1.59 (.82)

1.73 (.58)
.73

.93 (.68)

1.37

SCL-90-R
Depression (Pre)

1.99 (.78)

Depression (Post)

1.58 (1.04)

1.65 (.83)
.52

1.13 (.95)

.62

SCL-90-R
GSI (Pre)

1.62 (.60)

GSI (Post)

1.25 (.80)

1.35 (.53)
.62

.78 (.68)

1.07

SCL-90-R
2.21 (.44)

PSDI (Pre)

2.29 (.40)

PSDI (Post)

1.86 (.71)

1.09

1.50 (.77)

IES Intrusion (Pre)

2.2 (.63)

..

2.02 (.53)

1.63
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Table 3-Continued
EMD
IES Intrusion (Post) 1.21 (.89)

Effect Size

EMDR

1.61

1.25 (.78)

2.86

1.2 (.62)

1.54

11.5 (3.94)

SI-PTSD B (Pre)

11.09 (3.36)

SI-PTSD B
(Follow-up)

6 (1.30)

SI-PTSD C (Pre)

12.73 (6.48)

SI-PTSD
C (Follow-up)

8.8 (2.48)

SI-PTSD D (Pre)

10 (3.44)

SI-PTSD
D (Follow-up)

6.3 (1.73)

SI-PTSD
Total (Pre)

33.82 (10.94)

30.83(10.9)

SI-PTSD
Total (Follow-up)

21.1 (17.70) 1.16

16.64 (9.57)

BASA (Pre)

11.27 (7.36)

8.75 (4.56)

BASA (Follow-up)

4.5 (3.14)

SUDS (Pre)
SUDS (Post)
SUDS (1 month)

8.1 (1.52)
2.5 (1.5)
2.5 (2.17)

Mean Effect Size

. 1.45

2.02 (.53)

IES Avoidance (Pre) 2.36 (.34)
IES Avoidance (Post) 1.39 (.85)

Effect Size

1.52

5.27 (.95)

1.58

9.83 (5.37)
.61

5.55 (.56)

.80

9.5 (3.5)
1.08

5.82 (1.2)

1.05

1.29

.92

4.46 (4.89)

.94

3.68

8.46 (1.04)
3.09 (1.97)
3.9 (2.89)

4.39

] ]6
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Figu re 1. Mean SCL-90-R Anxiety Scores.
Figure 2 displays the change from pretest to post-test in group means for the SCL90-R depression scores. The means for both groups decreased from pretest to posttest.
A 2 x 2 repeated measures ANOVA indicated that this was a significant decrease. F
(1,21) = 6.83, p<.05. There were no significant differences between groups nor a
significant treatment by phase interaction.
Figure 3 displays the change from pretest to post-test in group means for the SCL90-R GSI scores. The 2 x 2 repeated measures ANOVA revealed a significant effect for
assessment phase, F (1,21) = 12.12, p<.01. There were no significant differences between
groups nor a significant group by phase interaction.
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Figure 4 displays the change from pretest to posttest in group means for the SCL90-R PSDI scores. For both groups the means decreased from pretest to posttest. The
2 x 2 ANOVA revealed that this finding was significant. F (1,21) = 12.08, p<.01. There
were no significant differences between groups no� a significant group by phase
interaction.
Figure 5 displays the change from pretest to posttest in group means for the IES
Intrusion scores. There was a consistent decrease in mean scores for both treatment
groups. The 2 x 2 ANOVA revealed that this was a significant decrease. F (1,21) =
30.33, p<.001. There was no significant group or interaction effect.
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Figure 5. Mean Impact of Events Intrusion Score.
Figure 6 displays the change from pretest to posttest in group means for the IES
Avoidance scores. Graphically, the results are very similar to the IES Intrusion scores.
The 2 x 2 ANOVA also revealed a significant effect for assessment phase, F (1,21) =
36.88, p<.001. There were no significant differences between groups nor a significant
group by phase interaction.
Figure 7 displays the change from pretest to 1 month follow-up in group means
for the SI-PTSD total scores. A 2 x 2 (group x assessment phase) ANOVA revealed a
significant effect for assessment phase F (1,19) = 49.13, p<.001). There was also a
significant effect for assessment phase for .SI-PTSD Category B, F (1,19) = 50.01,
p<.001; SI-PTSD Category C, F(l,19),; 19.64, p<.001; and SI-PTSD Category D, F
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(1,19)

=

26. 72, p<.001). There was no significant differences between groups nor a

significant group by phase interaction.
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Figure 6. Mean Impact of Events Avoidance Score.
Figure 8 displays the change in the mean SUDs scores across assessment phase.
Graphically, the mean SUDs scores appear to change at about the same rate. A 2 x 4
repeated measures ANOVA (group x assessment phase) revealed a significant effect for
groups, F (1,18) = 4.58, p<.05, and a significant effect for assessment phase F (1,18) =
42.30, p<.001. There was no significant group by phase interaction. Independent t-test
revealed a significant decrease in SUDs from the beginning to the end of treatment
(t= l0.10, p<.001), with no further significant changes at post-test or follow-up. An
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independent t-test conducted on mean SUDs scores at end of treatment revealed no
significant difference between the EMD and EMDR conditions.
Figure 9 displays the change in mean BASA scores from pretest to the 1 month
follow-up. The graphical presentation indicates a consi�tent decrease for both treatment
groups. A 2 x 2 ANOVA confirms that there was a significant effect for assessment
phase F(l, 19) = 10.31, p<.01, with no significant differences between groups nor a
significant group by phase interaction.
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Supplemental Analyses
Change in subjects' belief regarding the positive cognition was examined for
subjects in the EMDR group. Four ofthese subjects did not report a sufficient decrease
in anxiety by the end oftreatment (based on SUDs), and therefore end-state beliefin the
positive cognition was not addressed. The remaining 9 subjects reported a pre-treatment
VoC of3.67 and post-treatment VoC of6.56. A paired t-test revealed that this change
was significant at the . 001 level.
It was noted that all subjects tended to spontaneously report increases in positive
cognitions regardless of which
treatment. group they were in. In other words, it did not
.
seem to matter whether or not the therapist introduced a positive self-statement to the
client.
In addition to the primary dependent measures, all participants were instructed to
complete a daily checklist ofPTSD symptoms (See Appendix K). The checklists were
grouped into three assessment phases: (1) during treatment, (2) between treatment and
posttest, (3) from posttest to 1 month follow-up. Due to the poor compliance with
respect to this measure, there was a substantial amount ofmissing data. Three subjects
did not complete any ofthe checklists. Seven subjects had no data available for at least
one ofthe three assessment phases. Finally, even within assessment phases many subjects
failed to complete the checklists daily, prodt1cing variable numbers ofchecklists between
subjects.
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For these reasons, no statistical analysis could be performed on the data.

For

each subject, the raw scores within each phase were converted to proportions of total
symptoms across phases of assessment. Then, these proportions were averaged across
subjects within each assessment phase. Figure 10 represents the mean proportion of
symptoms endorsed within each phase.
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Figure 10. Mean Proportion of Symptoms on Daily Checklist.
Effect Size Analysis
In order to examine the clinical significance of the changes from pretreatment to
posttreatment (or follow-up), effect sizes were computed for all dependent measures.
The effect sizes are reported in Table 3. Iqgeneral, the effect sizes for the trauma-specific
measures tended to be of greater magnitude than the more general measures of

41
symptomology. Averaged across measures, the mean effect size for the EMD group
(1.24) did not differ from the mean effect size for the EMDR group (1.28).
On the measures where normative data were available (SCL-90-R and IES), mean
post-test scores were compared to the mean scores in the normative population. For both
the IES Intrusion and Avoidance subscales, end-state functioning of subjects in both the
EMD and EMDR groups were within the normal range. The more general measures of
psychological functioning (SCL-90-R) did not demonstrate this effect.
As an additional assessment of clinically- significant change, the proportion of
subjects that met diagnostic criteria for PTSD at the 1 month follow-up was examined.
At pretest, all subjects met either full PTSD criteria (70%) or qualified for the diagnosis
based on meeting criteria for two out of the three symptom clusters (30%). At the I
month follow-up, 20% of the sample still qualified for the diagnosis of PTSD and another
20% met the two-thirds diagnostic criteria. These results are presented graphically in
Figure 11.
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DISCUSSION
Evaluation ofthe Primary Hypotheses
The present study evaluated the cognitive reprocessing component ofEMDR by
comparing the standard procedure to a procedure that did not include the cognitive
component. In this investigation it was hypothesized that (a) the presenting complaints
associated with the traumatic memories would be reduced or eliminated as a result of
treatment; (b) self-report of anxiety would decrease; (c) positive self-cognition would
increase; (d) no differences would be found between treatment groups at post-test; and
(�) the null hypothesis ofno change from post to follow-up would be retained.
The first hypothesis was supported in this study. On all ofthe primary dependent
measures there was a statistically significant decrease from pretest to posttest (or follow
up). On both subscales ofthe IES, subjects end-state functioning was within the normal
range.
The second hypothesis, that the self report of anxiety would decrease, was
supported in the present investigation. The mean decrease in SUDs was from 8.23 at the
beginning oftreatment to 2.7 at the end oftreatment.
The third hypothesis, that the beliefin the positive cognition would increase was
also supported in this investigation. Subjects in the EMDR condition reported an increase
in VoC scores from 3.67 at pretreatment to 6.56 at posttreatment.
43

44
The fourth hypothesis, that no differences would be found between the EMD and
EMDR conditions was not entirely supported. On two measures (SCL-90-R anxiety and
SUDs scores) the difference between treatment groups using the repeated measures
ANOVA was significant at the .05 level. On these two measures, the EMDR group
showed fewer symptoms than the EMD group when the phases were ignored. However,
the analyses performed on the post-test means did not reveal a significant difference
between groups. Taken together, this does not necessarily indicate that the difference was
a result of the experimental manipulation. It is possible that the slight but non-significant
difference between groups at pre-test affected these results.
Finally, the fifth hypothesis, that there would be no significant change from
posttest to follow-up was supported. This hypothesis was supported based on SUDs data
only, as this was the only measure taken at both the post-test and the follow-up
assessments.
Comparisons With Previous Research
The reductions in symptoms reported on the outcome measures (SCL-90-R, IES,
SI-PTSD) in the present study are consistent with previous research on EMDR (Shapiro,
1989; Vaughan, et al., 1994; Wilson, Becker & Tinker, 1995). On one measure, the IES,
we found clinically significant decreases in symptoms to the extent that subjects could be
considered in the normal range across measures. Other researchers have reported similar
findings of clinically significant decreases rollowing EMDR treatment (Wilson, Becker &
Tinker, 1995).
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With respect to the SUDs data, the decreases reported in the present study are not
of the magnitude reported by Shapiro (1989). In that study, the mean SUDs scores at
post-treatment were less than 1, compared to 2.7 in the present study. The present
findings are more consistent with those of Sanderson and Carpenter (1992) and Wilson,
Becker & Tinker, (1995).
The finding of greater reductions on measures that directly assess PTSD
symptomology was consistent with previous research (Wilson, Becker & Tinker, 1995).
This finding may be understandable when one considers the way in which experiencing
a traumatic event can disrupt an individual's life. While treatment may produce rapid
relief from nightmares, anxiety, and avoidance, the effects of the trauma on other aspects
of life (depression, isolation) may be being maintained by other factors, or require greater
amounts of time for reductions to occur.
The present study supports the findings of previous research on cognitive
dismantling that found no difference in treatment conditions at post-test (Margraf,
Barlow, Clark & Telch, 1993; Marshall, 1985; Jacobson et al., 1996). Because data are
only available at the one month follow-up in this investigation, it is still unknown what the
longer term effects of the cognitive component may be.
The results of the present study also support previous EMDR studies that often
did not make use of the cognitive component, and yet still achieved positive outcomes
(Boudewyns, et al., 1993; Sanderson & CalJ)enter, 1992; Wolpe & Abrams, 1991). In
this investigation, not only did subjects.Improve regardless of treatment condition, but
subjects in the EMD condition were just as likely to report positive statements regarding

the traumatic event as were the subjects in the EMDR condition.
The finding that subjects who dropped out ofthe study had significantly higher
scores on several measures (SCL-90-R depression & GSI, IES Intrusion, SI-PTSD
Category B, D, and Total) is an issue that the literature has been silent on. While other
exposure-type treatments for PTSD (ie. flooding) have been criticized for the high
dropout rates (Solomon, Gerrity & Muff, 1992) many studies in the EMDR literature
have failed to mention drop out rates. This is an important consideration, in that ifthe
most severe PTSD cases are not following through with treatment, then it certainly limits
the generalizability ofconclusions regarding the efficacy ofEMDR.
The fact that the majority ofthe individuals who dropped out ofthe study were
in the EMD condition is consistent with the findings ofMargraf et al., 1992. In their
research, a condition that included a cognitive component had lower rates ofdropout in
treating Panic Disorder.. In the present study, it may be that the use of the positive
cognition in treatment provided a sense ofhope and rationale to continue treatment.
Strengths ofthe Present Study
The current investigation used standardized measures to assess pre- to post
change. The lack of standardized objective measures in the earlier investigations of
EMDR has been a repeated criticism (Herbert & Mueser, 1992; Lohr, Kleinknecht, et al.,
1993). An attempt was also made at definiqg change in PTSD symptomology in more
behavioral terms, through the use of the trained observers who rated overt signs of
anxiety during the structured interview.
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All subjects were randomly assigned to treatment condition. A treatment integrity
check was also performed in order to ensure that the treatments were being administered
reliably. All of the assessments were conducted by independent assessors. Finally,
follow-up assessments were included in the present study.
Limitations
The results of the present investigation need to be interpreted with caution due to
the small sample size. The sample size in this study is, however, well within the range of
previous studies that evaluated EMDR and studies more generally in the PTSD treatment
area.
Another limitation of this investigation is that while differences were not found
between treatment groups on most outcome measures, there was no measure that
assessed changes in cognitions for the EMD group. Although it was noted that subjects
in the EMD group also reported increased positive cognitions at the end of treatment, it
would be more informative to use measures that directly assess these changes in
comparison with the standard treatment.
Another limitation of the study involves the observers who were trained to rate
subjects' degree of distress on the modified version of the BASA While training
continued until a high degree of consistency was achieved, ideally the observers should
be trained to a specific criteria (ie. 95% agreement). Another limitation with respect to
the BASA involves when the ratings were taken. Observers rated subjects' distress
during the structured interview at pretest, and then again at the follow-up. During the
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pretest, subjects were asked to describe the traumatic events before being questioned on
their symptoms. At the follow-up interview, this reporting of the traumatic event was not
done. In retrospect, it appears that having the subjects be able to report on the trauma
with few displays of anxiety at the follow-up would have been a stronger indicator of
change.
An attempt was made to monitor the symptoms of PTSD daily through the use
of the checklists. Having subjects come to the clinic for only a few assessment periods
may not capture the fluctuations in symptoms that occur, or even the most severe of their
symptoms.

The poor compliance rate with this measure does not allow for

interpretations to be made regarding the outcome.
Future studies should address some of the above mentioned limitations.
Specifically, in order to determine if there is a unique contribution of the cognitive
reprocessing component, the use of measures that more directly assess cognitive change
in each condition is recommended. Future research may also want to examine the role
of the cognitive component by comparing standard EMDR to a procedure that makes
exclusive use of the cognitive component.
Conclusions
Adding to the literature that supports the efficacy ofEMDR in treating PTSD, the
present study found that EMDR was effective in reducing the symptoms related to
experiencing a traumatic event. Statistical analyses suggest that these findings were not
due to chance. Further, the majority of subjects no longer met criteria for the primary
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diagnosis of PTSD.
Findings with respect to the cognitive reprocessing component appear to support
the idea that this specific component of EMDR is not essential to treatment outcome.
Further research would need to be conducted in order to determine what contribution, if
any, this component makes.

Appendix A
Structured Interview for Post Traumatic Stress Disorder (SI-PTSD)
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ID#

Initials

Visit#

Date ______

§LCIT'llil� linnftcem®W ff®IT'
lF�llilililmlUbl� §� Il))mIT'mIT' (§II IrIT'OO}
0

Introduction
I shou ld li.ke to ask about the difficulties or problems that
caused you to come for help.
First would you please tell me your age:
Where do you live?
Are you employed?

If yes: What is your job?
If no:

When did you last work?
What did you do?
Why did you stop work?

With whom do you live?
Please tell
activities.

A.
A1

about

your

family

friends

and

social

Experience of Trauma
Did you ever experience,· witness or have to confront an
extremely stressful.. event which involved actual or
threatened death or serious injury, or a threat to the
physical integrity of yourself or others?
No

A2

me

4't)!,J

fl<i')c'.'.
j'r)Q.J:,"J &f

Fk-l. )�

Yes

,v;:&Or
Did you react to the event(s) with intense fear✓ helpl�ssness
or· horror?
t
Skrt- v--> / t'l"
No

Yes

1.

W{ 1

i<-

J.i.se,, 1 p h�

llfo..vv'l--0--

o,.,

D ):-

b{l�k_
�

cs+

52

How long were you in that situation?
What wa� th� w9�st thing about it for yo�?

-----'-------...- --------- -1---- ---.----------;---'='-;---A3

Define the event(s). Identify by the numbers below.
comment may be added.
Event
1
2
3
4
5
6
7
8
9
10
1.1.
1.2

A4

Age at event

= Combat

= Rape

= Incest

= Other physical assault/attack
= Seeing someone killed or hurt
= Natural disaster

= Accident

= Complicated bereavement
= Threat or close call

= Life-threatening illness

Captivity··
Other (identify)

Interviewer should make judgement whether the experiences
qualify for DSH-IIIR criterion of stressor: i.e. event is
outside range of usual experi ence and markedly distressing to
almost anyon e.
No

··

Narrative

Yes

B. Reexperiencing the Traumatic Event
After it was over, did you find yourself p ersistently
. remembering or dreaming about the events over and over
again for at least one month?
No

Yes

Did this happen even when you weren't trying to remember?
No

Yes
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Bi Recurrent intrusive recollections

Have you experienced painful images, thoughts or memories of
(.•....) trauma which you couldn't get out of your mind
even though you may have wanted to?
Have these been recurrent?
not at all
mild:_ rarely and/or not bothersome
moderate: at least once a week and/or produces some
distress
severe: at least 4 times per week .ar .moderately
distressing
extremely severe: daily or produces �·much
distress that patient cannot work or function
socially
Rate worst ever
Rate past 4 weeks (or other designated period)

)C{,:dET,
cu,h__. 1Af>
0 �A/,a�-+/4-

----

I'd like to ask you about your dreams.
Have you had repeated dreams of violence, combat or death (or
ther theme related to trauma)?
�
:,. �
Were these of actual scenes you were involved in?
Do you recognize people in the dream?
Are these dreams of the event?
How frequent are these dreams?
Do
you
wake up sweating or
Palpitations? Trouble breathing?

shouting?

Trembling?

Are the nightmares so bad that your spouse (partner) does not
sleep in the same bed, or in the same room?
o
1
2
3 =
4

no problems
mild: infrequent or not disruptive
moder.ate; at least once a week/somewhat distressing
severe: at least four times a week/moderately
distressing
extremely severe: six to seven times a week/
• ·-• - •• -extremely distressing

Rate worst ever
Rate past 4 weeks (or other designated period)._____
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B3 Acting or �eeling a s if event was currently happening
At times have you reacted to something as if you were back in
combat, reliving rape or other relevant trauma? Has it see.med
that the event was recurring or that you were living throuch
it again? Did you have hallucinations of the event?

a =
l
2
3

4

=
=
=
=

not at all
rarely
sometimes
often
every week

Rate worst ever
Rate past 4 weeks (or other designated periad)�--B4 Intense psychological distre·ss at exposure· to reminders o� event
Do any of the symptoms occur or get worse if something reminds
you of the stressful event? Ask about TV programs, weather
conditions, news, Veterans' Day, recent disaster involving the
loss of life, loss of good friends, being in places which
. remind person of the event. (Feel angry, sad,· irritable,·
anxious, frightened?)
o
l
2
3

=

4

=

not at all
a little bit: infrequent or of questionable
significance
somewhat: one or two symptoms occur
significantly: several symptoms occur or one sympto�
with much distress
marked: very distressing, may have activated an
episode of the illness, resulting in hospitalization,
different treatment, etc.

Rate worst ever
Rate past 4 weeks (or other designated period)
BS Does exposure to an event that reminds you of or resembles the
t r auma, cause you to have any physical response?
(Sweating,
trembling, heart racing, nausea, hyperventilating, feeling
�rozen; do not include nightmares.)
o = not at all
l
a little bit: infrequent or questionable
2 = somewhat: mildly distressing
3. ==... $ignificantly: causes much distress
. 4 =. marked:· very distressing or has sought help from
doctors because of the physical response (e.g. I chest
:· pain so. severe 1;:hat patient was sure he or she was
:havinc�(}i. heart attack)
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Rate worst ever
Rate past 4 weeks (or other designated period)

c_

Avoidance of Stimuli Associated with the Trauma

C1 Have you persistently tried to avoid thoughts, feelings or

conversations about the trauma?

.week.s?

No

Did thi.s last at lea.st four

Yes

0 = no avoidance
1 = mild: of doubtful significance
2 = moderate: definite effort: is made, but is able to
function at work and socially
3 = s evere: definite avoidance which affects life i n some
way (keeps moving from place to place/cannot
work/works excessively/or episodic substance
abuse because of need to a,void thoughts or feelings)
4 = very severe: dramatic ef'fect on life·

Rate worst ever
Rate past 4 weeks (or other designated period)
C2 Avoidance of activities that arouse recollection of the event
Have you persistently avoided places, people or occasions that
remind you of the event? Did this l;;.st at least four weeks?
Yes

No
Moyies?
Noisy
Other places?
0
l

places?

·- _�--

Veterans'

meetings?

Funerals?

= no avoidance
= mild: of doubtful significance (uncomfortable but

doesn't a void)
2 = moderate: definite avoidance of situations
3.= severe: very uncomfortable and avoidance affects life
i n some way
4 = Extremely severe: house-bound, cannot go out to
s hops and restaurants
Rate worst ever
Rate past 4 weeks (or other designated period)
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C3 Psychogenic amnesia

Is there a n important part of the event that you cannot
remember?
O = no problem: remembers everything
1 = mild: remembers most details
2 = moderate: some difficulty remembe�ing significant
details
3 = severe: remembers only a few details
4 = very severe: claims total amnesia for the trau:ma
Rate worst ever
Rate past 4 weeks (or other designated,pe.J:".iod)

What things have you lost interest in;
enjoy?
O
1
2
3
4

=
=
=
=
=

�--

What do you stil l

n o loss of interest
one or two activities less pleasurable
several activities less pleasurable
most activities less pleasurable
almost all activities less pleasurable

Rate worst ever.
-·� r
•

_.:...•••. -. ·····-.

.r

-- --

Rate p<ei_§t 4 ,1�eks ( or other designated period) ___�_
CS Detachment/estrangement
Do you have less to do with other people than you used to?
Do you feel estranged from other people?
o = no problem·
1 = feels detached/estranged, but still has normal degree
of contact with others
2 = sometimes avoids contact that would normally
participate in
3 = definitely and usually avoids people with whom would·
previously associate
4 = absolutely refuses or actively avoids all social.
contact since the stress
Rate worst ever
Rate past 4 weeks

or other designated period)

... --···-··--···--··-·-···---•--·-·-·····-··-·•'·--�---- --·····-

····-· -·-··•··•---�-
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C6 Restricted range of affect

Can you have warm feelings/feel close to others?
numb? Was it different before?
0 =
l. =
2 =
3 =
4 =

Do you feel

no problem
mild: of questionable significance
moderate: some difficulty expressing feelings
severe: definite problems with expressing feelings
very severe: have no f.eelings, feels nUlilb most of the
time

·:.,,:--.,•
Rate worst ever
Rate past 4 weeks (or other designated .;ieri��).

C7 For.eshortened future
What do you see happening in your future?
What do you visualize as you grow old?
expectations of the future?

What are

your

O = describes positive or realistic future
l = mild: describes pessimistic outlook at times, but
varies from day to day depending on events
2 = moderate: pessimistic much of the time
severe: constantly pessimistic
3
can see no future/ views early death as likely ( but
4
without adequate medical basis)
Rate worst ever
Rate past 4 weeks ( or.other designated period)

D. Increased Arousal
D1 Sleep disturbances
We spoke earlier about nightmares-what about other aspects of
sleeping? Have you had trouble falling asleep? ·
Do you wake in the middle of the night?,
Are you unable to go back to sleep after waking?
O
no loss of sleep
.l = mild: occasional difficulty but no more than two
nights/week
2 = moderate: difficulty sleeping at least three
nights/week
3 = severe: difficulty sleeping every night
4
extremely severe: less than 3 hours sleep/night

Rate worst ever
Rate past 4 weeks (or other designated period)
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, D2 Have you been moi;,e irritable or more easily annoyed than usual.'?
How did you s how yvur feelings? Have you ha,d angry outbursts?
o = not at all
1 = mild: occasional feelings of annoyance or anger
which may go unnoticed by others
2 = moderate: increased feelings of annuyanoe,"'�comes,,
s nappy or argumentative ( at least once ,every 2
weeks); others may have commented
severe: almost constantly irritable or angry/often
3
l oses temper or has significant impairment in ability
t o relate to others as a result of this4 = very severe; preoccupied with anger or feelings of
retaliation, overtly aggressive or assaultive/marked
impairment in function
0

Rate worst ever
Rate past 4 weeks (or other designated period)

--·----

D3 Impairment in concentration
Have you noticed any trouble concentrating?
Is it hard to keep your mind on things?
Can you pay attention easily?

1 •

What about reading or watching TY]
o
no difficulty
1 = serial subtraction, 1 mistake out of 5; or p atient
acknowledges slight problem
2 = serial subtraction;· 2 mistakes out of 5; .or patient
describes definite difficulty
3
serial subtraction; 3 mistakes out of-.5; interferes
with daily activities, job, etc.
4 = serial subtraction, 4 or 5 mistakes, -or w·ill. not even
attempt subtraction; constant problems, unable to do
simple tasks
Rate worst ..ever
Rate past 4 weeks ( or other designated period)
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D4 Hypervigilance
Do you have to stay on guard?
you feel on edge?

Are you easily distracted?

0 = no problem
l = mild: occasional/not disruptive
2
moderate: causes discomfort/ feel�_ o� edge
or watchful in some situations
3 = severe: causes discomfort/feels on edge or
watchful in most situations
4 = very severe: causes extreme discomfort and
alters life (feels constantly en ��t
keep back to wall/socially impaired
��use
·
feeling on edge)

Do

.of

Rate worst ever
Rate past 4 weeks (or other designated period)
DS Startle
Do you startle easily? Do you have a tendency to jump? Is
this a problem after unexpected noise, or if you hear or see
.something that reminds you of (the original trauma)?
0 = no problem
l = mild: occasional but not disruptive
2 = moderate: causes definite discomfort or an
exaggerated startle response at least eve�� 2 weeks
J
severe: happens more than once a week
extremely severe: so bad that patient cannot function
4
at work or socially
Rate worst ever
Rate past 4 weeks (or other designated period)
D6 Behavior/survival guilt

of

Are you troubled by feelings
guilt or sha:me for what you
did in combat, (or rape or another situat�on)?
Do you feel that you did not deserve to survive ?
Have you felt guilty about surviving?
O = no guilt
l = mild: sometimes feels guilty, but basically takes the
view of "I did my job" or "I did the best I could in
that situation".
2
moderate: expresses some distress because of these
feelings, or feels guilty much of the time
J = severe: constant feelings of guilt, which may evoke
significant distress
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4 = extremely severe: preoccupied with these feelings
Rate worst ever behavior guilt
Rate past 4 weeks ( or other designated period)
behavior guilt *(Do not include in total score)

�
---

Rate worst ever survival guilt
Rate past 4 weeks (or other designated-·period)
survival guilt
*(Do not include in total score)

E. How long has this condition lasted?
E1.

Did the symptoms which you have desc-ribea 1ast �or
at least four weeks?

E2.

How many months after the trauma did these symptoms
�irst develop?--�
Age at the time

F. In the interviewer's judgement, and taking in to account the subject's
responses, has the disturbance caused clinically significant distress or
impairment in social, occupational or other important areas of
functioning?
Na

, ..
§:>

:· ,.

Yes

i ,-i..:__

7r·=�..:...,......, (�.. -1{
Initial.s
B

ID# _____
DATE _____
W�l':i'<-r
1
2
3

4
5

(Subtotal.)
C

1
2
3

4
5

6
7

(Subtotal.)
D

1
2
3

4
5

(Subtotal.)
Total. (B,C, D1-D5)
D6

VISIT #

P�.
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Total worst ever score for all appropriate B, C
and D items.
Do not include D-6 when score is totaled.
Total present (past 4 weeks or other designat.ad. _ period)
score for all appropriate B, C and D items

Score No as 1, Yes as 2 to all answers below:
DSM-ill-R Diagnosis

Traumatic event definitely present?
At least one item from B 1-4 with score
of at least 2
At least three items from category C with score
of at least 2.
At least cne item frcm BS and D 1-5 vith score of at least 2.
All items (categories B,C and D) present at least
one month?
Past diagnosis·?

Present diagnosis?

I

DSM-IV Diagno�

�umat-i;·�-;�nt definitely present?
-· . __ ,.
_____,-At least one item from category B with
·) C)L•1
score of at least 2
,.,
__At least three items from category C with score
� \of at least 2 (at least one item must be.from
..c 1-2 and one must be from C 3-7)
j-'' ·,
At least two items from category D 1-5 (each must
score at least 2)
Past diagnosis

Present diagnosis
� . : :·.�- .... _;, ,,.. . ,_.::......

·,

·1 .. _.i !

...-1 I i,,.

L- '·':
\.._i

total

total

Appendix B
Symptom Checklist-90-R (SCL-90-R)
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Permission to reprint the SCL-90-R was not granted by the authors.

Appendix C
Impact of Events Scale (IES)
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Impact of Events Scale

you
(date)
experienced
On
__ __ ____ _________
___________ ____ _ (life event). Below is a list of comments
made by people after stressful life events. Please check each item, indicating how
frequently these comments were true for you DURING THE PAST 7 DAYS. If they did
not occur during that time, please mark the "not at all" column.
0 = Not at all

l = Rarely

2 = Sometimes

3 = Often

0

2

3

2. I avoided letting myself get upset when I thought about
it or was reminded of it.

0

2

3

3. I tried to remove it from memory.

0

2

3

4. I had trouble falling/ staying asleep because
pictures or thoughts about it came into my mind.

0

2

5. I had waves of strong feelings about it.

0

2

6. I had dreams about it.

0

2

_,

7. I stayed away from reminders of it.

0

')

_,

8. I felt as if it hadn't happened or it wasn't real.

0

9. I tried not to talk about it.

0

10. Pictures about it popped into my mind.

1. I thought about it when 1 didn't mean to.
-·

_)

2

3

2

_,

0

2

_,

11. Other things kept making me think about it.

0

2

.-,

12. I was aware that I still had a lot of feelings about it,
but I didn't deal with them.

0

2

3

13. I tried not to think about it.

0

2

14. Any reminder brought back feelings about it.

0

2

15. My feelings about it were kind of numb.

0

2

1

AppendixD
Drug Abuse Screening Test (DAST)
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Drug Abuse Screeing Test
Subject:__________

Date:__}__J_

Please respond to the following questions based on your involvement with drugs or alcohol
within the last month.
No
Yes
l}Do you use drugs other than those needed for medical reasons?........... (_)
2)Do you abuse prescription drugs?.....,........................................ (_)
3)Do you abuse more than one drug at a time?.................................. (_)
4)Can you get through the week without using drugs?......................... __ (_)
5)Are you always able to stop using drugs when you want?..................
(_)
6)Do you abuse drugs on a continuous basis?................................. (_)
7)Do you try to limit your drug use to certain situations?..................... (_)
8)Have you had blackouts or flashbacks as a result of drug use?....:-...... (_)
9)Do you feel bad about your drug abuse?..................................... (_)
lO)Does your spouse (parents) ever complain about your involvement
with drugs?.......................................................................... (_)
ll)Do your friends or relatives know or suspect you abuse drugs?.......... (_)
12)Is drug abuse creating problems between you and your spouse?........ (_)
13)Has any family member sought help for problems related to your
drug use?............................................................................ (_)
14)Have you lost friends because of your drug use?........................... (_)
15)Have you neglected your family or missed work because of your
use of drugs?....................................................................... (_)
16)Have you been in trouble at work because of drug abuse?................. (_)
l 7)Have you lost a job because of drug abuse?................................. (_)
18)Have you gotten into fights when under the influence of drugs?.......... (_)
19)Have you been arrested because of unusual behavior while
under the influence of drugs? ...................................................... (_)
20)Have you been arrested for driving under the influence of drugs?........ (_)
2l}Have you engaged in illegal activities in order to obtain drugs?........... ( _)
22)Have you been arrested for possession of illegal drugs?................... (_)
23)Have you experienced withdrawal symptoms as a result of heavy
drug intake? .......................................................................... (_)
24)Have you had medical problems because of your drug use (e.g.,
hepatitis, memory loss)? ........................................................... (_)
25)Have you gone to anyone for help for a drug problem?.................... (_)
26)Have you ever been in the hospital for medical problems related to
your drug use? ....................................................................... (_)
27)Have you been involved in a treatment program specifically related
to drug use? .......................................................................... (_)
28)Have you been treated as an out-patient for problems related to drug
abuse? ................................................................................ (_)
Are you currently taking any prescription drugs for your symptoms that resulted from the
trauma?Yes__No__
If so, which one(s)? _____ _______________

.

How long have you been taking this medication? __________

Appendix E
Personality Screener
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Procedures for Personality Assessments
1. Inform subject that you will be reading them a list of statements that may or may not be
true for them.
2. For each statement, ask them if this is a) not characteristic of me; b) a little bit true for
me, or sometimes true; or c) definintely characteristic of me.
3. Ask that they consider how they view their own behavior, as well as how others close to
them report that they behave.
Next to each item, write down the number 0-2 that corresponds to their answer.
characteristic of me; 1 =a little bit true for me, or sometimes true; 2=definitely
characteristic of me)
I.

(0=not

a. engaging in frantic efforts to avoid real or imagined abandonment (don't include
suicidal or self-mutilating behavior)
__ b. having a pattern of unstable and intense interpersonal relationships characterized by
alternating between extremes of idealizing and devaluing the other person
__ c. having a disturbance in identity with a noticable and persisten-tly unstable self-image
__ d. engaging in recurrent suicidal behavior, gestures, or threats, or self-mutilating
behavior
__ e. exhibiting emotional instability due to a distinct reactivity of mood - mood swings (ie.
intense episodic depressed mood, irritability, or anxiety usually lastig a few hours and rarely
more than a few days)
__ f. having chronic feelings of emptiness
__ g. having inappropriate, intense anger or difficulty controlling anger (frequent displays
of temper, constant anger, recurrent physical fights)
II.

a. Being preoccupied with details, rules, lists, order, organization or schedules to the
extent that the major point of activity is lost
__ b. showing perfectionism that interferes with task completion (ie. unable to complete a
project because overly strict standards are not met)
c. Being overconscientious, scrupulous, and inflexible about matters of morality,
ethics, or values (not accounted for by cultural or religious identification).
__ d. Being reluctant to delegate tasks or to work with others unless they submit to exactly
my way of doing things
e. showing rigidity and stubbornness
I. = Borderline scale
11. = Obsessive-Compulsive scale

Appendix F
Modified Behavioral Assessment of Speech Anxiety (BASA)
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Session (pre/lmonth/2month):___ __ __
Subject#_____
Observer: _______

Modified Behavioral Assessment of Speech Anxiety (BASA)

Following is a list of ways in which anxiety may be behaviorally manifested during a
therapy session with a client who is recounting a traumatic memory. Each behavioral
manifestation may occur in varying degrees of severity, which may be quantified
according to the following rating scale:
0

not at all

1
slight

2
moderate

3
strong

For each behavioral manifestation of anxiety that occurs during the interview session,
mark your rating (from Oto 3) to indicate how severe it was.
Voice _____
1. Quivering or tense voice
__ 2. Too fast
__3. Too soft
__4. Loud/pressured speech
Verbal fluency____
__ l. Nonfluencies, stammers, halting
__2. Vocalized pauses ("Umm")
__ 3. Hunts for words, speech blocks
Mouth and throat._____
1. Swallows
__2. Clears throat
__ 3. Breathes heavily
__4. Breathes quickly
Facial expression_____
__ l. Lack of eye contact, extraneous eye movements
__ 2. Tense face muscles, grimaces, twitches
__ 3. "Deadpan" facial expression
Anns and hands______
__ 1. Rigid or tense
__2. Fidgeting, extraneous movements
__ 3. Wringing hands
Gross bodily movements____
1. Rocks
__2. Holds self
Overt autonomic arousal ___
1. Tears
__ 2. Sobbing
__3. Trembling
__4. Perspiring
__5. Sniffling/runny nose
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Treatment Observer Rating Checklist
Place a check next to each of the components that the therapist engages in.

1. Has subject identify most distressing image
2. Asks subject to assign SUDS
3. Has subject develop positive cognition
4. Asks subject to assign VoC
5. Has subject engage in saccadic eye movements
6. Asks for a report on changes
7. Ask for VoC after SUDS reaches O or l
8. Has subject hold image and positive cognition in mind while engaging in eye
movements

AppendixH
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In fonned Consent fo r Participation in an Investigation
Western Michigan University
Department of Psychology

Principal Investigator/Advisor: C.Richard Spates. PhD
Co-Principal Investigator: Karen Cusack

I have been invited to participate in the Post Traumatic Stress Screening and Treatment
Project in a study entitled "Eye Movement Desensitization and Reprocessin� in the
Treatment of PTSD: A Procedural Dismantling." I understand that this project is under the
direction of Dr. C. Richard Spates and Karen Cusack of the Psychology Department at
Western Michigan University. I further understand this research is intended to study the
relative efficacy of one of two variations of a treatment for Post Traumatic Stress Disorder.
I understand that I will not know which procedure I will receive until assigned by the
researcher. I understand that in either procedure I will be required to recall certain aspects
of a traumatic experience as part of therapy. I further understand that the treatment will be
provided by a trained therapist and will be under the supervision of Dr. Spates at all times.

My consent to participate in this project indicates that I understand that I will be asked to
attend two initial assessment sessions, 1-3 90 minute treatment sessions, depending on
how well the treatment works for me, and that I will be asked to return to the Psychology
Clinic at approximately one week, one month, and two months after the last treatment
session to complete questionnaires or go through a follow-up interview. All sessions will
be conducted at the WMU Psychology Clinic by therapists trained in the use of the
procedures.
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During the first (assessment) session I will be asked to complete three questionnaires.
During the second (assessment) session I will be given one structured interview and one
additional questionnaire. The first questionnaire, the Symptom-Checklist-90-Revised
(SCL-90-R) asks me to respond to 90 short statements about a wide range of feelings,
thoughts, and activities.

The second questionnaire, the Personality Diagnosis

Questionnaire (PDQ-4), contains questions about my patterns of relating to other people
and how I view myself.

The third questionnaire will ask about any drug and alcohol use

in which I take part at the present time. The fourth questionnaire, the Impact of Events
Scale (IES), will ask about my responses to the traumatic event that I experienced. The
Structured Interview for Post-traumatic Stress Disorder (SI-PTSD) asks me to respond to
questions about my thoughts, feelings, and physical responses regarding the traumatic
event/s that I experienced. Each of these assessment sessions will take approximately one
hour. I understand that as a result of these assessments, I may not qualify for participation
in the study. In that case, and if I desire counseling, I may be provided with a therapist
referral list.

This list might assist me in seeking suitable treatment at my own expense

elsewhere if I so choose.

As in all research, there may be unexpected risks to the participant. If an accidental injury
occurs, appropriate emergency measures will be taken; however, no compensation or
treatment will be made available tQ me except as otherwise specified in this consent form. I
understand that one potential risk of my participation is this project is that I may be upset by
the content of the assessment or treatment sessions. I understand, however, that Dr.
Spates, Karen Cusac�, or another Psychology Clinic staff member is prepared to offer
crisis counseling should I become significantly upset and that I would not be responsible
for the cost of such crisis intervention. A determination as to the degree of distress I
experience will be continually -assessed by experienced professional psychologist(s).
When in their professional j_udgement I become distressed to the point where I should no
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longer continue with the treatment, the session will be terminated. Should additional
treatment be deemed appropriate, Psychology Clinic staff are prepared to make a referral if
I need further counseling. I will be responsible for the cost of therapy if I choose to pursue
it.

I understand that at various points my assessment or treatment sessions may be observed.
This observation would be for purposes of training, or to ensure the reliable administration
of the treatment procedures only. I also understand that at times, it may be necessary to
videotape a session for training purposes. I understand that my session would only be
videotaped with my permission. If I agree, a separate consent form will be given to me on
the day videotaping is being requested. My signature on that form will indicate that I give
my permission to be videotaped for that session only. All videotapes will be kept strictly
confidential. The tapes will be kept in a locked box in the clinic. Only Karen Cusack, Dr.
Richard Spates, and research assisstants currently being trained in the procedures will have
access to the material on the tape. Once all of the data are collected, the videotape will be
erased.

One way in which I may benefit from this activity is having the chance to express my
feelings about the trauma, which research indicates is beneficial for individuals who have
suffered from a traumatic event. I also understand that others who have experienced a
traumatic event may benefit from the knowledge that is gained from this research.

I understand that all the information collected from me is confidential. That means that my
name will not appear on any papers on which this information is recorded. The forms will
all be coded and Karen Cusack will keep a separate master list with the names of
participants and the corresponding code numbers.

Once the data are collected and

analyzed, the master list will be destroyed. All other forms will be retained for one year
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following completion of the study in a locked file in the Western Michigan University
Psychology Clinic. Information will be kept on computer disk for at least a pericxi of five
years after that ix>int.

I understand that I may refuse to participate or quit at any time during the study without
prejudice or penalty. If I have any questions or concerns about this study, I may contact
either Karen Cusack at 342-1335 or Dr. Spates at 387-8332. I may also contact the Chair
of the Human Subjects Institutional Review Board at 387-8293 or the Vice President for
Research at 387-8298 with any concerns that I have. My signature below indicates that I
understand the purpose and requirements of the study and that I agree to participate.

Signature

Date
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Procedures for EMDR Sessions

Before session be�ins:
Get client file
Check that you have 14 daily checklists to give to subject
Check file to see which procedure is being administered (EMDR or EMD)
Remember to ask for the checklists from the previous week
Make sure kleenex is available
Seat the subject comfortably. however they will be most comfortable.
Establish rapport. This should consist of just some light conversation to put the subject at
ease. Generally you will have had the chance to begin this on the elevator ride down.
Ask them to describe the trauma. You might say, "I've read about the __ (fire, auto
accident ) that you were involved in. I'd like to take a few minutes to have you tell me a
little more about that". Establishing rapport and description of trauma should take around
10 min.
Before going into treatment description you may want to say something like, "Thank you
for sharing that with me, I can see that it's not easy to talk about. Before we get started I
would like to explain a little bit about the treatment".
Treatment Description
Inform the subject that you will be asking them to:
1) recall the traumatic event and keep it in mind and
2) follow your fingers with their eyes for about 30 seconds at a time then
3)briefly resting and providing you with information regarding recall of the event.
4)let them know you will also be asking for a rating regarding how he/she is feeling
emotionally/physically at approximately 5-7 minute intervals.
Then say: "At various points during today's session, I am going to move myfingers
across yourfield of vision, like this (demonstrate this using a couple of back and forth
movements). In a moment I will be moving my chair closer to you and we will practice the
technique. First, there are a few things I'd like you to keep in mind.

1) ft is important that you recall all aspects of the experience, including the specifics of
what happened (the "story"), your thoughts and evaluations about it, and your vhvsical and
emotional reactions to what happened to you.
( In other words, it is important that the person address not only the events themselves but
the physiological, cognitive and emotional responses as well.)

2) ff you have experienced more than one traumatic event, you should begin by addressing
the most recent one. If you have experienced an event with a nwnber of parts, you should
begin by addressing the most upsetting part.
As today's session goes on I will be giving you specific instructions as to certain things
you should be aware of when you start moving your eyes. After many of the groups of
eye movements I will be taking a p!zysiology check. I need to know from you exactly what
is going on with as clear feedback as possible. Sometimes things will change and
sometimes they won't. I may ask you if the picture changes- sometimes it wi/i ar.d
sometimes it won't. f'/l ask you how you fee/from Oto 10. Sometimes it will change and
sometimes it won't. There are.no supposed to's in this process. So just give as accurate
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feedback as you can as to what is happening without judging whether it should be
happening or not. Just let whatever happens, happen."
"Remember, whenever I move my fingers in form! of you, it is important that you do the
best you can to follow them with your eyes. If you wish to stop, tell me or signal me. If
your eyes stop moving without you letting me know I will encourage you to keep them
moving. If you have difficulty following I will make adjustments to help you continue. I
would like you to keep your head still but follow my moving fingers with your eyes.
Let's practice the technique now. (Move chair closer)
Practice, doing one full set of eye movements. If adjustments need to be made it would be
here that you would detem:une this. (ie. lower, diagonal, further away)
Piv otal Ima�e
Please visualize the most unpleasant moment from the episode and pay attention to the
negative feeling that goes with the scene... On a scale of0 to IOwith IO being most
uncomfortable and 0 being not uncomfortable at all where is your feeling now with that
scene in mind? ... What is the name of that uncomfortable feeling? ... Where do you feel it
in your body?.. .
Pr esent/ Ne�ative Co�ition
You might want to ask for this by saying, "If the image were a snapshot, what caption
could you write underneath it that would best communicate your thoughts about what
happened? What do you tend to say to yourself when that image comes to mind?"
If having trouble you may suggest some relevant cognitions from the list.
Des ired Co�nition
You could say, "What would you like to be able to believe or think or say to yourself when
you see that image?"
VoC Ratings: "On a scale of 1-7, where Us not at all true, and 7 is completely true, how
true does that statement seem to be for you?"
Be�n Treatment:
"Now take a moment to conjure up the image of what happened. With this in mind also
recall your physical and emotionnl feelings at the time. I'll give you a moment to get this all
in mind, and ask you to follow myfingers with your eyes when you are ready. (Wait
briefly) O.K. Now with that in mind.follow my fingers ...
After about 23-26 saccades, stop and say, "Blank it out, take a deep breath. (Pause
briefly). "Tell me what comes up now I what do you notice now I What changes now?
Remember... you are looking for thoughts, feelings, and body sensations. If they are
consistently reporting just scenes, you may want to ask, "What do you feel? or "What
physical feelings do you have in your body"
After every 4th set of saccades yoy will be asking for a SUDs rating. "On a scale from Oto
JOwhere 0 is completely calm and JOis the most distress possible for you, lww would
you rate what you are feeling aow?"
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Continue with sets of saccades, talcing SUDs scores every 4th set, until they reach a O or 1
OR until they have remained consistently low (3). Try for complete desensitization, but if
you are in your last session and nearing the end, getting two consecutive 3's is sufficient.
At this time ask the subject to recall the desired cognition as well as the rating they gave it.
Ask them to hold this statement in mind and do 2 sets of saccades. Then take VoC rating
on it. Continue with saccades, taking a rating every other set, until the VoC has reached a
7, or remains at .6.

Installation Phase
Ask subject to hold in mind the orignal (pivotal) image and the desired cognition. Do 2
s.ets of saccades. Remember with this phase and the desired cognition phase you are just
asking them to hold it in mind and follow your finger. There: are no "what comes up?" in
these phases.
You should have about 15 minutes towards the end for the VoC and th� installation phase.
The session should be limited to 1 hour 15 minutes.
At the end of the last session you will take them upstairs to schedue the 1 week post-test
session. Also, remember that they need 14 more daily checklists!
Good luck!!!
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Procedures for EMD Sessions

Before session be�ns:

Get client file
Check that you have 14 daily checklists to give to subject
Check file to see which procedure is being administered (EMDR or EMD)
Remember to ask for the checklists from the previous week
Make sure Kleenex is available

Seat the subject comfortably, however they will be most comfortable.
Establish fiU2port. This should consist of just some light conversation to put the subject at
ease.

Ask them to describe the trauma. You might say, "I've read about the __ (fire, auto

accident) that you were involved in. I'd like to take a few minutes to have you tell me a
little more about that". Establishing rapport and description of trawna should take around
10 min.

Before going into treatment description you may want to say something like, "Thank you
for sharing that with me, I can see that it's not easy to talk about. Before we get started I
would like to explain a little bit about the treatment".

Treatment Description

Inform the subject that you will be asking them to:
1) recall the traumatic event and keep it in mind and
2) follow your fingers with their eyes for about 30 seconds at a time then
3)briefly resting and providing you with information regarding recall of the event
4)let them know you will also be asking for a rating regarding how he/she is feeling
emotionally/physically at approximately 5-7 minute intervals.

Then say: "At various points during today's session, I am going to move my fingers
across your field of vision, like this (demonstrate this using a couple of back and forth
movements). In a moment I will be moving my chair closer to you and we will practice the
technique. First, there are a few things I'd like you to keep in mind.

1) It is important that you recall all aspects of the experience, including the specifics of
what happened (the "story"), your thoughts and evaluations about it, and your physical and
emotional reactions to what happened to you.
( In other words, it is important that the person address not only the events themselves but
the physiological, cognitive and emotional responses as well.)

2) If they have experienced more than one traumatic event, they should begin by addressing
the most recent one. If they have experienced an event with a number of parts, they should
begin by addressing the most upsetting part
As today's session goes on I will be giving you specific instructions as to certain things
you should be aware of when you start moving your eyes. After many of the groups of
eye movements I will be taking a physiology check. I need to know from you exactly what
is going on with as clear feedback as possible. Sometimes things will change and
sometimes they won't. I may ask you if the picture changes- sometimes it will and
sometimes it won't. I'll ask you how you feel from Oto 10. Sometimes it will change and
sometimes it won't. There areJzo supposed to's in this process. So just give as accurate
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feedback as you can as to what is happening without judging whether it should be
happening or not. Just let whatever happens, happen."
"Remember, whenever I move my fingers in front of you, it is important that you do the
best you can to follow them with your eyes. If you wish to stop, tell me or signal me. If
your eyes stop moving without you letting me know I will encourage you to keep them
moving. If you have difficulty following I will make adjustments to help you continue. I
would like you to keep your head still but follow my moving fingers with your eyes.
Let's practice the technique now. (Move chair closer)

Practice, doing one full set of eye movements. If adjustments need to be made it would be
here that you would detennine this. (i.e.. lower, diagonal, further away)

Pivotal Irnaee
Please visualize the most unpleasant momentfrom the episode and pay attention to the
negative feeling that goes with the scene... On a scale ofO to JO with 10 being most
uncomfortable and 0 being not uncomfortable at all where is your feeling now with that
scene in mind? ... What is the name of that uncomfortable feeling? ... Where do you feel it
in your body? .. .

Present/ Neeative Coi,1ition
You might want to ask for this by saying, "What words best go with the picture and
express your belief about yourself?" or What do you tend to say to yourself when that
image comes to mind?"
If having trouble you may suggest some relevant cognitions from the list. Keep in mind
that if you are still having trouble you don't want to hold up treatment for this. An
appropriate cognition 'will present itself as treatment progresses if you are really stuck.

Bectn Treatment:
"Now take a moment to conjure up the image of what happened. With this in mind also
recall your physical and emotional feelings at the time. I'll give you a moment to get this all
in mind, and ask you to follow my fingers with your eyes when you are ready. (Wait
briefly) O.K. Now with that in mind, follow my fingers ...

After about 23-26 saccades, stop and say, "Blank it out, take a deep breath. (Pause
briefly). 'Tell me what comes up now I what (U) you notice now I What changes now?
Remember... you are looking for thoughts, feelings, and body sensations. If they are
consistently reporting just scenes, you may want to ask, "What do you feel? or "What
physical feelings do you have in your body"
After every 4th set of saccades you will be asking for a SUDs rating. "On a scale from Oto
IO where 0 is completely calm and 10 is the most distress possible for you, how would
you rate what you are feeling now?"
Continue with sets of saccades, taking SUDs scores every 4th set, until they reach a O or 1
OR until they have remained consistently low (3). Try for complete desensitization, but if
you are in your last session and nearing the erid, getting two consecutive 3's is sufficient.
If there is still time remaining, and their SUDs is all the way down to O or 1, still give them
an extra 4 sets so that this proc�ure will parallel the EMDR procedure.
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The session should be limited to I hour and 15 minutes.
At the end of the last session you will take them upstairs to schedule the 1 week post-test
session. Check my calendar in the Cusack & research assistants mailbox. Both Chad and
Amy's schedules are written in there so you know when you can schedule these sessions.
Please write the appointment in this book. Also remember that they need 14 more daily
checklists.
Good Luck!!!.
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Subject u_·_______
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Date_ ____
_
_
Daily Stress Checklist
Below is a list of statements that describe some of the feelings people ofieil have after a

s tressful ever.t. Please respond to each statement that was true for you today by
placing a check next to that statement
1. Did you avoid activities associated with the event? _
2. _Did you feel angry? _
3. Did it interfere with your ability to perform at work? _
4. W,15', your temper short with family members? _
5. Did your emotional state change without warning? _._
6. Did you have trouble in remembering things? _
7. Did you stay away_ from social gatherings?
8. Did you lose trust in other people? _
9. Did you feel afraid or helpless? _
10. Did you try to avoid thinking about what happened?
11. Did you question whether or not life was worth living? _
12. Did you experience nightmares about what happened? _
13. Were there times when you didn't know what to do next? _
14. Did you have difficulty in sleeping through the night? _
15. Did you feel "numb" or unable to relate to other people? _
16. Were you afraid to return to the place where it occurred? ___
17. Was your temper short with people at work? _
18. _Did you feel like crying when you thought about what happened?
19. Did your sexual desire decrease? _
20. Did thoughts about what happened keep returning?
21. Did you feel that you must be on your guard? _
22.- Did itinterfere with your social life or personal relationships?
23. Did you feel thaiothers couldn't understand what it was like?
24. Did you have trouble falling asleep? _·_
25. Did you feel that it was happening again? _
26. Did you l_lave trouble in concentrating? _
27. Were you easily startled or upset by things that reminded you of it?
28. Did you "block" when you tried to think about what happened?
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Kalamazoo, Michigan 49008-3899

Human Subjects Institutional Review Board

616 387-8293

WESTERN MICHIGAN UNIVERSITY

Date:

August 15, 1995

To:

Karen Cusack

. ��
From: Richard Wright, Chai�
Re:

G:�-t

HSIRB Project Number 95-07-01

This letter will serve as confirmation that your research project entitled "Eye movement
desensitization and reprocessing in the treatment of post traumatic stress disorder: A procedural
dismantling" has been approved under the full category of review by the Human Subjects
Institutional Review Board. The conditions and duration of this approval are specified in the
Policies of Western Michigan University. You may now begin to implement the research as
described in the application.
Please note that you must seek specific approval for any changes in this design. You must also
seek reapproval if the project extends beyond the termination date. In addition if there are any
unanticipated adverse reactions or unanticipated events associated with the conduct of this research,
you should immediately suspend the project and contact the Chair of the HSIRB for consultation.
The Board wishes you success in the pursuit of your research goals.
Approval Termination:
xc:

Spates, PSY

Aug. 15, 1996
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vour memo d;i.t.ed October 18. 1995 h;i;ve been armroved bv the Hv.man Sv.biects Institutional
Review Board. This chan[!es are;
1.

!?_emo'/e the exclusion criteri�- for P�.n.ic Disorder.

2.

Adovt a less restrictive inclusion critreia for PTSD.

�.L

The conditions and the duration of this annroval are snecified in the Policies of Western MichirI,rn
Universitv.
You must seek reavvroval for anv chaMes in this desie-n. You must also seek reanvroval if the
vroiect extends bevond the termination date.
The Board wishes vou success in the vursuit of your research rroals.
Annroval Termination:
xc:

October 25. 1996

C. Richaxd Svaxes. PSY
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Human Subjects Institutional Review Board

Kalamazoo, Michigan 49008-3899
616 387-8293

WESTERN MICHIGAN UNIVERSITY

Dare:

December 6, 1995

To:

Karen Cusack

rrom: Richard Wright, Chair
Re:

HSIRB Project Number 95-07-01

This letter will serve as confirmation that the changes to your research project "Eye movement
desensitazation and reprocessing: aprocedural dismantling" requested in your memo dated
November 28, 1995 have been approved by the Human Subjects Institutional Review Board wi.r h
one addtional minor change in your original consent form. Please indicate in the consent form that
subjects may be asked to be videotaped during the course of the project.
The conditions and the duration of this approval are specified in the Policies of Western Mi.chi.gan
University.
You must seek reapproval for any changes in this design. You must also seek reapproval if the
project extends beyond the termination date.
The Board wishes you success in the pursuit of your research goals.
Approval Termination:
xc:

October 25, 1996

C. Richard Spates, PSY
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